BioSpace News Archive

AstraZeneca and Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved LYNPARZA in combination with bevacizumab as a first-line maintenance treatment of adult patients with advanced epithelial ovarian,

Surgery Partners, Inc., a leading short-stay surgical facility owner and operator, announced a change in the format for the Company’s 2020 annual meeting of stockholders by filing additional proxy materials with the Securities and Exchange Commission.

Today, the U.S. Food and Drug Administration approved Retevmo (selpercatinib) capsules to treat three types of tumors – non-small cell lung cancer, medullary thyroid cancer and other types of thyroid cancers – in patients whose tumors have an alteration (mutation or fusion) in a specific gene (RET or “rearranged during transfection”).

DexCom, Inc. announced that, due to the public health impact of the COVID-19 pandemic, the location of the 2020 Annual Meeting of Stockholders of DexCom, Inc. has been changed and will be held as a hybrid meeting that stockholders can attend either in person or virtually via live webcast, though the Company strongly encourages stockholders to participate virtually.

21st Century Oncology, the largest integrated cancer care network in the nation, has completed the joint venture partnership with Landmark Cancer Center.

The U.S. Food and Drug Administration continued to take action in the ongoing response effort to the COVID-19 pandemic

MiMedx Group, Inc., an industry leader in advanced wound care and an emerging therapeutic biologics company, announced that it is repaying the Payment Protection Program Loan received through its application to the Federal relief effort.

Check-Cap Ltd. announced that it has entered into definitive agreements with several institutional and accredited investors for the purchase and sale of 5,000,000 of the Company’s ordinary shares, at a purchase price of $0.60 per share, in a registered direct offering.

The global allergy immunotherapies market is on an upward growth curve and is set to witness a plethora of growth opportunities arising in its landscape.

Autoimmune disease diagnostics market has gained traction due to growing efforts by several vendors undertaking research activities to discover novel biomarkers.